Did you know that Evosep Biolabs facilitate large-scale cohort studies to advance precision medicine. This means you get easy access to our state-of-the-art facility and expertise in proteomics. Combined with your own genomic information and next-generation sequencing this enables a deeper understanding of biological systems. Why Choose Evosep Biolabs? Multi-Omics Approach: Uncover molecular mechanisms of diseases. Biomarker Discovery: Identify new biomarkers for early detection and treatment. Personalized Therapeutics: Develop personalized therapeutic strategies for better patient outcomes. Join us in revolutionizing healthcare and unlocking the secrets of biology with our cutting-edge technologies. #evosepbiolabs #proteomics #lcms
Evosep Biosystems’ Post
More Relevant Posts
-
Multi-omics Data Analysis Made Easy with #ExpOmics: A Comprehensive Web Platform for Robust Analysis 🎯 ExpOmics, developed by Guangzhou Medical University scientists, allows researchers to explore diverse data types (genes, proteins, RNA) across species & generate high-quality visualizations. Quick Read: https://lnkd.in/gqynZN3g #bioinformatics #omics #genomics #dataanalysis #webserver #bigdata #cancer #biologists #sciencenews
-
-
Spatial Omics Market Through 2024-2033 . The spatial omics market size has grown rapidly in recent years. It will grow from $0.27 billion in 2023 to $0.3 billion in 2024 at a compound annual growth rate (CAGR) of 11.3%. The growth in the historic period can be attributed to the rising number of genetic disorders, increasing prevalence of cancer, increasing demand for personalized medicine, growing demand for biomarker identification and validation, increasing adoption of spatial genomics, and transcriptomics and proteomics. . The spatial omics market size is expected to see rapid growth in the next few years. It will grow to $0.46 billion in 2028 at a compound annual growth rate (CAGR) of 11.5%. The growth in the forecast period can be attributed to increased research and development activities, increased financing for OMICS research, development of transformational approaches for cancer biomarker discovery, increased translational research, and economic growth. Major trends in the forecast period include Strategic collaborations and partnerships, spatial omics techniques, integration of advanced technologies, product innovations, and technological advancement. . Read More @ https://lnkd.in/gVjYvc_W . #marketresearch #marketintelligence #marketreport #industryanalysis #TheBusinessResearchCompany #TBRC #GlobalMarketModel
-
-
Unlock the full potential of multiomics without the complexity. Traditional multiomics requires multiple approaches, and complex workflows. Imagine if genomic, epigenomic, and transcriptomic information (including single-cell and spatial insights) was accessible from just a single platform. With nanopore technology, this is a reality. Discover how researchers are using nanopore sequencing to uncover new biomolecule-disease connections, key signaling pathways, and disease biomarkers. Learn more: https://bit.ly/48XIMtI wymm #AACR24
-
The solution for your luxury problem of having too much spatial data? Let us analyze it for you. See how in this webinar.
In this webinar, Xiomara Perez, PhD and Farhat Mustafa, from our Professional Assay Services (PAS) team will provide an overview of how to visualize the changing cellular dynamics within your tissue and gain insight into your specific research questions. We will review spatial analysis of target antigens, biomarkers, cytokines, and CAR-T cells together with immune cell distribution within the tumor microenvironment and discuss how our powerful image analysis tools can answer your questions by quantifying your target markers using customized approaches. #AdvancingYourRNAscopeISH #SpatialMultiomics #PAS #SeeMorein2024 When: February 13, 2024 @7am PST Register: https://lnkd.in/ePhnjsdc
PAS Webinar: Visualize and Analyze Spatial Patterns of Your Target within the Tissue Micro-Environment | ACD | ACD Inc.
info.bio-techne.com
-
Global Scientific Director Integrated Healthcare Solutions, Personalized Medicine Oncology chez Roche
Great research and evidence to continuously improve patient care.
With over 20 pieces of research, we’re excited to share new data around the emerging applications of our liquid biopsy & monitoring portfolio, as well as studies investigating new biomarkers and the expanding utility of comprehensive genomic profiling, including Foundation Medicine’s new RNA test. Click the link to learn more about everything we’re presenting at #ASCO24: https://bit.ly/3WNlYdJ
Foundation Medicine at 2024 ASCO® Annual Meeting
-
Hub for Integrated Informatics and Research Support at AIDS and Cancer Specimen Resource
Advancing Spatial Biology to the Clinic: The Power of Multiplex #Immunofluorescence-based Biomarkers for Companion Diagnostics Webinar: Monday, June 10, 2024 | 2pm EDT / 11am PDT Learn about immunofluorescence-based biomarker analysis with key considerations for developing a companion diagnostic. Register today! #researchmatters #spatialbiology
Advancing Spatial Biology to the Clinic: The Power of Multiplex Immunofluorescence-based Biomarkers for Companion Diagnostics
xtalks.com
-
Innovative Leader | Connector | Motivator | People Focused | Problem Solver Extraordinaire | Product Launch Wizard | 21 years of striving for excellence
Our data at ASCO this year highlights the important role genomic profiling plays in cancer care and research and can be grouped into four major buckets: - Emerging Applications of Liquid Biopsy Using FoundationOne®Liquid CDx and FoundationOne®Tracker. - Utility of CGP in Earlier Stages of Disease, Rare Cancers, and Using RNA Sequencing. - New CGP Biomarkers, Including Homologous Recombination Deficiency (HRD) Signature and Methyl Thioadenosine Phosphorylase (MTAP) Genomic Loss. - Impact of Ancestry on the Genomic Alteration Landscape.
With over 20 pieces of research, we’re excited to share new data around the emerging applications of our liquid biopsy & monitoring portfolio, as well as studies investigating new biomarkers and the expanding utility of comprehensive genomic profiling, including Foundation Medicine’s new RNA test. Click the link to learn more about everything we’re presenting at #ASCO24: https://bit.ly/3WNlYdJ
Foundation Medicine at 2024 ASCO® Annual Meeting
-
If you are in the Immuno-Oncology space, check out the presentation by our Corinne Ramos about the composite biomarker they are developing at our lab in Lille, France that can help better predict patient responses to IO therapies! Please message me if you would like to discuss further. #Aliri #Bioanalysis #SpatialBiomarkers #ImmunoOncology #PatientStratification
Aliri Bioanalysis scientists at our lab in Lille, France, recently developed a composite biomarker that integrates the spatial distribution of metabolites with genomic profiling, transcending traditional methods of predicting patient responses to immuno-oncology therapy. Learn more: https://lnkd.in/euVkZhQA #SpatialBiomarkers #GenomicProfiling #PatientStratification #ImmunoOncology
-
International Customer Experience Lead - Foundation Medicine at Roche Diagnostics
Ahead of the curve…
With over 20 pieces of research, we’re excited to share new data around the emerging applications of our liquid biopsy & monitoring portfolio, as well as studies investigating new biomarkers and the expanding utility of comprehensive genomic profiling, including Foundation Medicine’s new RNA test. Click the link to learn more about everything we’re presenting at #ASCO24: https://bit.ly/3WNlYdJ
Foundation Medicine at 2024 ASCO® Annual Meeting
-
Global Scientific Director | Multi-omics, Biomarkers | mMBA in Pharma | Assistant Professor
Dear #multiomics friends! Wanted to share with you some discussion points we had in the last COST Action AtheroNET meeting in Valencia! 📌Which clinical bio markers for #cardiovascular disease are validated and approved? 📌Could MultiOmics enable biomarker discovery? 📌Do we need big number of data in order to identify relative bio markers? 📌How can we integrate medical immagine procedure with molecular diagnostic tools based on Omics? Happy to hear your thoughts! 👏👏👏🔥 #crowdsource #crowdsourcing #biomarker #biomarkerdiscovery #clinicaldata Olink Proteomics #cardioresearch
-
More from this author
-
Complete Automated Sample Preparation Workflow for Scalable Clinical Proteomics with Evotip: A Game Changer for Biomarker discovery
-
Unleash the potential of large-scale proteomics
-
Advancements in Technology Setting new Standards for Scalable Single-Cell Proteomics: Identification of Over 5,000 Proteins in a Single HeLa Cell